ТераФлю® from flu and cold

General characteristics. Structure:

Active components: paracetamol of 325 mg, pheniramine maleate of 20 mg, Phenylephrinum hydrochloride of 10 mg, ascorbic acid of 50 mg;

auxiliary components: malic acid, sodium citrate dihydrate, dye yellow No. 6, dye yellow No. 10, titanium dioxide, sucrose, lemon fragrance, trekhosnovny phosphate of calcium, anhydrous citric acid.

Description: The loose white granulated powder with yellow impregnations without lumps and foreign particles with a citrus smell.

Pharmacological properties:

The combined drug, possesses the febrifugal, antiinflammatory, antiedematous, anesthetizing, antiallergic action.

Indications to use:

Infectious and inflammatory diseases (SARS, flu) which are followed by high temperature, a strong fever, an ache in a body, head and muscular pain, cold, a nose congestion, sneezing.

Route of administration and doses:

Inside.

To dissolve contents of one bag in 1 glass of boiled hot water. To use hot. It is possible to add sugar to taste.

It is possible to accept a repeated dose every 4 hour (no more than 3 doses within 24 hours).

ТераФлю® from flu and cold it is possible to apply at any time, but the best effect brings administration of drug before going to bed, for the night. If relief of symptoms within 3 days after the beginning of administration of drug is not observed, it is necessary to see a doctor.

Features of use:

In order to avoid toxic damage of a liver drug should not be combined using alcoholic beverages.

At administration of drug it is not recommended to drive the car or other mechanisms.

It is not necessary to use medicine in the damaged bags.

Side effects:

Allergic reactions (rash, itch, urticaria, Quincke's disease), hyperexcitability, reduction in the rate of psychomotor reactions, feeling of fatigue, dryness in a mouth, an ischuria, nausea, vomiting, stomach aches, heartbeat, increase in arterial pressure, dizziness, a sleep disorder, a mydriasis, accommodation paresis, increase in intraocular pressure are possible.

Considering availability of paracetamol: seldom - disturbances of system of blood (anemia, thrombocytopenia, a leukopenia, an agranulocytosis); at long reception of high doses hepatotoxic and nephrotoxic action, hemolitic anemia, a methemoglobinemia, a pancytopenia are possible.

Interaction with other medicines:

It is recommended to refrain from administration of drug at reception of inhibitors of a monoamnooksidaza. The risk of a hepatotoxic action of paracetamol increases at co-administration of barbiturates, dipheninum, carbamazepine, rifampicin, a zidovudine and other inductors of microsomal enzymes of a liver.

Strengthens effect of sedatives, ethanol. Ethanol strengthens sedative effect of pheniramine. Antidepressants, protivoparkinsonichesky and antipsychotic means, fenotiazinovy derivatives increase risk of development of an ischuria, dryness in a mouth, locks.

Contraindications:

Hypersensitivity to separate components of drug. Pregnancy, breastfeeding period. Portal hypertensia, alcoholism, renal failure, deficit of enzyme glyukozo-6-fosfatdegidrogenazy.

Not to apply at children up to 12 years.

With care to apply at: arterial hypertension, a diabetes mellitus, closed-angle glaucoma, a serious illness of a liver or kidneys, lungs (including to bronchial asthma), difficulties of an urination at prostate adenoma, blood diseases, inborn hyperbilirubinemias (Gilbert's syndromes, the Cudgel Johnson and Roterum).

Overdose:

Nausea, vomiting, pains in epigastric area; hepatotoxic and nephrotoxic action, in hard cases develops a liver failure, encephalopathy and coma.

Treatment: a gastric lavage, absorbent carbon in the first 6 h, introduction of donators of SH-group and predecessors of synthesis of glutathione - methionine in 8-9 h after overdose and N-Acetylcysteinum in 12 h.

Storage conditions:

At a temperature from 15 °C to 30 °C in the dry place protected from light. To store in the place, unavailable to children. Period of validity: 2 years. Drug should not be used after expiry date

Issue conditions:

Without recipe

Packaging:

Powder for preparation of solution for intake dosed 22,1 g.

On 22,1 g of powder in a bag from the combined material (polyethylene, aluminum foil, polyethylene/paper). On 6, 8, 10 or 12 bags in a cardboard pack. The application instruction is applied on a bag.